EQT Private Equity Acquires 20% Stake in 3Shape

EQT Acquires Minority Stake in SHL Medical

January 3, 2020

Medical Devices

EQT VIII (EQT) has agreed to acquire a minority stake in SHL Medical, a Switzerland-headquartered manufacturer of advanced drug delivery devices including autoinjectors. The investment will support SHL's next phase of growth, innovation and digitization while leveraging EQT's healthcare expertise; the deal is subject to customary regulatory approvals.

EQT Acquires Majority Stake in Ellab from IK Investment Partners

August 7, 2019

Medical Devices

EQT Mid Market Europe has agreed to acquire a majority interest in Ellab A/S from the IK VIII Fund (advised by IK Investment Partners). EQT will partner with Ellab's management, which will retain a minority stake, to accelerate global growth by expanding R&D, enhancing the go-to-market model in the US and Europe, and growing the company's as-a-service offerings.

EQT Private Equity to Acquire Zeus Company Inc

December 18, 2023

Medical Devices

EQT Private Equity (via its EQT X fund) has entered into an agreement to acquire Zeus Company, Inc., a global leader in advanced polymer components for medical devices, from the Tourville family. EQT plans to support Zeus with investments in production capacity, R&D, and operational improvements to accelerate growth in minimally invasive medical device markets.

EQT Future and ATHOS Lead Minority Investment in SHL Medical

December 9, 2022

Medical Devices

EQT Future, ATHOS and other co-investors have acquired a minority stake in SHL Medical from EQT's Equity fund VIII, with founder Roger Samuelsson remaining the majority shareholder. The consortium will support SHL Medical's next growth phase — expanding production into the United States and Europe, launching new product platforms, and advancing sustainability and circularity initiatives.

EQT Acquires Majority Stake in CluePoints

June 12, 2024

AI & Machine Learning

EQT (via its Healthcare Growth strategy and the EQT Growth Fund) has agreed to acquire a majority stake in CluePoints, a Belgium-headquartered provider of AI-powered RBQM and clinical trial data analytics software. Existing investors Summit Partners and Clinimetrics SA (and management) will reinvest; the deal is intended to support CluePoints' continued product development, global expansion and entry into adjacent markets and is expected to close in Q3 2024.

EQT IX Acquires Majority Stake in thinkproject

November 16, 2020

Cloud & SaaS

EQT IX (EQT Partners) has acquired a majority stake in thinkproject, a Munich-based SaaS construction intelligence platform, from TA Associates and founder Thomas Bachmaier. The transaction will support thinkproject's product extension, geographic expansion and consolidation strategy while management and sellers are reinvesting in the company.